Rxsight Inc (RXST) Stock Price, Quote & News

Company Profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 521 7830

Website: www.rxsight.com

Address:

100 Columbia, Aliso Viejo, United States

drockafeller Aug. 5 at 12:52 AM

$RXST new addition to the board of directors that has built up medical device companies.

0 · Reply

MadMaverick Aug. 4 at 4:42 PM

📉JOIN THE $7 SWING TRADING CLUB ✅ Weekly Top 5 Swing Picks ✅ Private Chat Access ✅ Live Market Updates ✅ Daily Watchlist Hub ✅ Entries & Targets Mapped Out 👉 https://whop.com/checkout/plan_8fe7j4EELtsjJ/?a=madmaverick&d2c=true 👈 $CONI $SRPT $RXST $SPY $QQQ

1 · Reply

BretEmmerich Jul. 29 at 6:32 PM

$RXST what alternative companies offer their own LAL lens? What companies and names?

2 · Reply

johsmith Jul. 24 at 8:09 PM

$RXST looks cheap. Very solid cash position and management seems to be aware what needs to be done to improve sales. Still watching...

1 · Reply

prodigy81 Jul. 23 at 7:27 PM

$RXST Hmm...I learned this ticker right now. It seems this is down huge. Any upcoming catalysts?

2 · Reply

Kabita84 Jul. 23 at 3:56 PM

$RXST i made money last drop..

0 · Reply

Kabita84 Jul. 23 at 3:56 PM

$RXST as i said this will go to 10 without any excuse..and 25 dollar value stock.

0 · Reply

Savagebull Jul. 21 at 2:48 PM

$RXST run from this turd

0 · Reply

Averagejoe68 Jul. 18 at 1:57 PM

$RXST 😁

0 · Reply

daleloyd Jul. 17 at 1:51 PM

$RXST dead money for a while .

0 · Reply

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST

Aug 4, 2025, 4:53 PM EDT - 1 day ago

Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

Aug 4, 2025, 8:05 AM EDT - 1 day ago

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

Jul 30, 2025, 8:36 AM EDT - 6 days ago

RXST INVESTORS: RxSight, Inc. (NASDAQ:RXST) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses

Jul 28, 2025, 8:36 AM EDT - 8 days ago

RXST LAWSUIT: RxSight, Inc. Sued for Fraud after LDD Sales Plummet – Contact BFA Law by September 22 Court Deadline (NASDAQ:RXST)

Jul 25, 2025, 2:26 PM EDT - 11 days ago

Berger Montague PC Investigates Securities Claims Against RxSight, Inc. (NASDAQ: RXST)

Jul 23, 2025, 4:56 PM EDT - 13 days ago

RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jul 23, 2025, 11:50 AM EDT - 13 days ago

RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With Large Losses in RxSight Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jul 21, 2025, 1:09 PM EDT - 15 days ago

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST

Jul 21, 2025, 10:21 AM EDT - 15 days ago

RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm

Jul 20, 2025, 7:08 AM EDT - 16 days ago

RXST SECURITIES NEWS: Did RxSight, Inc. (NASDAQ:RXST) Commit Securities Fraud? Contact BFA Law about its Investigation into the Company

Jul 18, 2025, 9:07 AM EDT - 18 days ago

RXST INVESTIGATION: RxSight, Inc. (NASDAQ:RXST) 38% Stock Drop Triggers Securities Fraud Investigation – Contact BFA Law if You Lost Money

Jul 15, 2025, 5:18 PM EDT - 21 days ago

Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders

Jul 11, 2025, 10:12 AM EDT - 25 days ago

Johnson Fistel Begins Investigation on Behalf of RxSight, Inc. (RXST) Shareholders

Jul 9, 2025, 1:33 PM EDT - 27 days ago

Crude Oil Moves Higher; RxSight Shares Plunge

Jul 9, 2025, 8:18 AM EDT - 27 days ago

Aehr Test Systems Posts Downbeat Sales, Joins RxSight, Vertical Aerospace And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

AEHR EVTL

Jul 8, 2025, 4:05 PM EDT - 4 weeks ago

RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance

Jun 7, 2025, 9:32 AM EDT - 2 months ago

RxSight: Valuation Blowout Creates Opportunity

May 20, 2025, 4:10 PM EDT - 2 months ago

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

May 9, 2025, 7:16 AM EDT - 3 months ago

Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

PRTA SRPT

May 7, 2025, 11:04 PM EDT - 3 months ago

RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 3 months ago

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Apr 3, 2025, 5:57 PM EDT - 4 months ago

RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)

Apr 3, 2025, 3:54 PM EDT - 4 months ago

RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)

Apr 2, 2025, 8:00 PM EDT - 4 months ago

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

Mar 25, 2025, 4:05 PM EDT - 4 months ago

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Feb 26, 2025, 6:35 AM EST - 5 months ago

RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 5 months ago

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

Jan 12, 2025, 9:30 AM EST - 7 months ago

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

Jan 2, 2025, 4:05 PM EST - 7 months ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Nov 29, 2024, 12:04 PM EST - 8 months ago

RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye

Nov 9, 2024, 1:32 PM EST - 9 months ago

RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 4:05 PM EDT - 10 months ago

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

Aug 22, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

Aug 13, 2024, 4:50 PM EDT - 1 year ago

Investing In The Future Of Cataract Surgery: The RxSight Advantage

Aug 5, 2024, 9:45 PM EDT - 1 year ago

RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Reports Second Quarter 2024 Financial Results

Jul 22, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

Jun 5, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

May 13, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

drockafeller Aug. 5 at 12:52 AM

$RXST new addition to the board of directors that has built up medical device companies.

0 · Reply

MadMaverick Aug. 4 at 4:42 PM

1 · Reply

BretEmmerich Jul. 29 at 6:32 PM

$RXST what alternative companies offer their own LAL lens? What companies and names?

2 · Reply

johsmith Jul. 24 at 8:09 PM

$RXST looks cheap. Very solid cash position and management seems to be aware what needs to be done to improve sales. Still watching...

1 · Reply

prodigy81 Jul. 23 at 7:27 PM

$RXST Hmm...I learned this ticker right now. It seems this is down huge. Any upcoming catalysts?

2 · Reply

Kabita84 Jul. 23 at 3:56 PM

$RXST i made money last drop..

0 · Reply

Kabita84 Jul. 23 at 3:56 PM

$RXST as i said this will go to 10 without any excuse..and 25 dollar value stock.

0 · Reply

Savagebull Jul. 21 at 2:48 PM

$RXST run from this turd

0 · Reply

Averagejoe68 Jul. 18 at 1:57 PM

$RXST 😁

0 · Reply

daleloyd Jul. 17 at 1:51 PM

$RXST dead money for a while .

0 · Reply

Iunited267 Jul. 16 at 5:00 PM

$RXST Great tech, useless stock

0 · Reply

Dunn94 Jul. 15 at 2:57 PM

$RXST

0 · Reply

BryGuy29 Jul. 15 at 2:18 PM

$RXST geez. When will the bleeding stop?

0 · Reply

Sam313 Jul. 14 at 1:37 AM

$RXST

0 · Reply

Omegacy2 Jul. 12 at 8:35 PM

i used to buy stocks that are cheap friday for monday bounce. $ZETA is one of them. i have order to shorted and misses order 15.99 and hod 15.86 etc... bc market are expensive. $ZETA friday i am in 13.9-14.01 for a bounce monday 14.5-15+. after that it depend of market condition. if zeta have an good articles that pump ai software zeta used for news. analysts pt 25. it pre er rally or not. @kenarcher i am in for a bounce and scalps many +5-10% $HELE $BYRN $CAPR $RXST since few days. msgs posted.

1 · Reply

Iunited267 Jul. 11 at 6:29 PM

$RXST I think this will settle 7.30-7.70 for now

0 · Reply

Sam313 Jul. 11 at 11:31 AM

$RXST

0 · Reply

Omegacy2 Jul. 10 at 11:45 PM

i have scalps yesterday 3x $RXST +0.3-1.3. in 6.3s and today i misses +0.8 order 7.51 and lod 7.65. today i scalp 3x $HELE +1-2.5 from in 21.9s 2x $BYRN +0.3-1 that is double the maximum profits by scalping instead of holding. @Phil_Leotardo69 a moron and a loser to lol at $SPY 510 my called msg below for +5-10% and +25% have come. Apr 21, 2025 11:49 AM $SPY 510 i pt 515-520+ bc each times spy drop 3-5% and it bounce +5-10%. since spy 505 called. 5x times i dip buy for a bounce 3-5x +5-25% nvda nbis rh and i re shorted vxx 74-76. i have scalps 5x +5-25% from 72-87.5

0 · Reply

daleloyd Jul. 10 at 11:26 PM

$RXST buying here is a no-brainer

0 · Reply

Sam313 Jul. 10 at 8:47 PM

$RXST 12

0 · Reply

Sam313 Jul. 10 at 6:24 PM

$RXST 12

0 · Reply

daleloyd Jul. 10 at 4:35 PM

$RXST this is an amazing opportunity at this price 💰

0 · Reply

Market Cap	321.85M
Revenue (ttm)	139.93M
Net Income (ttm)	-27.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.62%
Debt to Equity Ratio	0.00

Volume	1,005,700
Avg Vol	1,290,996
Day's Range	N/A - N/A
Shares Out	40.64M
Stochastic %K	13%
Beta	1.16
Analysts	Hold
Price Target	$12.22